MedPath

University of Pennsylvania

University of Pennsylvania logo
🇺🇸United States
Ownership
Private
Established
1740-11-14
Employees
5K
Market Cap
-
Website
http://www.upenn.edu

The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder

Phase 4
Completed
Conditions
Premenstrual Syndrome
Premenstrual Dysphoric Disorder
Interventions
First Posted Date
2008-05-15
Last Posted Date
2018-07-27
Lead Sponsor
University of Pennsylvania
Target Recruit Count
45
Registration Number
NCT00678574
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-05-12
Last Posted Date
2017-06-01
Lead Sponsor
University of Pennsylvania
Target Recruit Count
8
Registration Number
NCT00676026
Locations
🇺🇸

Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health, New Haven, Connecticut, United States

Seroquel for Frequent, Heavy Drinkers

Phase 2
Completed
Conditions
Alcoholism
Interventions
Drug: Placebo
Drug: Seroquel
First Posted Date
2008-05-08
Last Posted Date
2014-09-17
Lead Sponsor
University of Pennsylvania
Target Recruit Count
156
Registration Number
NCT00674765
Locations
🇺🇸

University of Pennsylvania, Treatment Research Center, Philadelphia, Pennsylvania, United States

Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant

Phase 1
Terminated
Conditions
Chronic Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Acute Myelogenous Leukemia
Hodgkin's Disease
Myelodysplastic Syndrome
Multiple Myeloma
Non-Hodgkin's Lymphoma
Chronic Lymphocytic Leukemia
Interventions
Biological: CD3/CD28 Activated T cells
First Posted Date
2008-05-07
Last Posted Date
2020-08-17
Lead Sponsor
University of Pennsylvania
Target Recruit Count
13
Registration Number
NCT00674427
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Changes in Sexual Function Following Bariatric Surgery

Not Applicable
Completed
Conditions
Obesity
Interventions
Procedure: Bariatric surgery
Behavioral: lifestyle intervention (behavioral weight loss)
First Posted Date
2008-05-01
Last Posted Date
2015-10-22
Lead Sponsor
University of Pennsylvania
Target Recruit Count
207
Registration Number
NCT00670098

The Role of Partial Reinforcement in the Long Term Management of Insomnia

Not Applicable
Completed
Conditions
Primary Insomnia
Interventions
Drug: Zolpidem
Drug: Placebos
First Posted Date
2008-04-21
Last Posted Date
2017-08-07
Lead Sponsor
University of Pennsylvania
Target Recruit Count
129
Registration Number
NCT00662155
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression

Phase 2
Completed
Conditions
Depression
Interventions
Drug: S-citalopram
Behavioral: Cognitive behavioral therapy (CBT)
Procedure: TRODAT-1 single photon emission computed tomographic (SPECT) imaging
First Posted Date
2008-04-09
Last Posted Date
2020-04-16
Lead Sponsor
University of Pennsylvania
Target Recruit Count
66
Registration Number
NCT00655057
Locations
🇺🇸

Depression Research Unit - University of Pennsylvania, Philadelphia, Pennsylvania, United States

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Phase 2
Completed
Conditions
Metastatic Differentiated Thyroid Cancer
Metastatic Anaplastic Thyroid Cancer
Metastatic Medullary Thyroid Cancer
Metastatic Poorly Differentiated Thyroid Cancer
Interventions
First Posted Date
2008-04-07
Last Posted Date
2019-11-18
Lead Sponsor
University of Pennsylvania
Target Recruit Count
59
Registration Number
NCT00654238
Locations
🇺🇸

University of Pennsylvania - Abramson Comprehensive Cancer Center, Philadelphia, Pennsylvania, United States

The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial

Phase 2
Completed
Conditions
Spinal Ischemia
Stroke
Neuroprotection
Interventions
Drug: Darbepoetin alfa
Other: Standard care
First Posted Date
2008-04-01
Last Posted Date
2017-06-05
Lead Sponsor
University of Pennsylvania
Target Recruit Count
18
Registration Number
NCT00647998
Locations
🇺🇸

The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Genetics of Polycystic Ovary Syndrome

Completed
Conditions
PCOS
First Posted Date
2008-03-31
Last Posted Date
2013-05-13
Lead Sponsor
University of Pennsylvania
Target Recruit Count
189
Registration Number
NCT00647335
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath